Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 7 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
COVID can seriously damage your vision, even if you didn’t have symptoms, new study says. Experts...
Fortune via Yahoo Finance· 2 hours agoUsing a humanized mice model, Singh and his team showed that the prolonged presence of SARS-CoV-2...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 4 days agoIt's approved by the Food and Drug Administration for the treatment of adults who are newly infected...
Will FLiRT COVID variants bring another summer surge? What to know about symptoms and potential for...
Fortune via Yahoo Finance· 6 days ago“The mutations will keep happening.” The Omicron variant of SARS-CoV-2, the coronavirus that causes...
Paxlovid Doesn't Cure Long COVID
Time via Yahoo News· 4 days agoMost people in the study...nirmatrelvir from breaking down too quickly. The rest of the group took a placebo with ritonavir, which doesn't work against...
Paxlovid fails to improve long COVID symptoms in small study
Center for Infectious Disease Research and Policy· 4 days agoAll enrollees reported at least 3 months of postacute sequelae of SARS-CoV-2 infection (PASC) ...
Positive test not needed for long COVID diagnosis, experts conclude
Medical Xpress· 5 days agoPeople do not need to have tested positive for the coronavirus to be considered for a diagnosis of...
Virus Behind COVID-19 Could Linger In Sperm For 110 Days After Infection Starts
IFLScience· 6 days agoA team of researchers from Brazil set out to address this knowledge gap. Semen samples were...
Paxlovid tied to 34% lower risk of hospitalization in adolescent COVID patients
Center for Infectious Disease Research and Policy· 12 hours agoNo safety concerns were reported after Paxlovid use.
Paxlovid Fails First Test in Long COVID
MedPage Today· 4 days agoA 15-day course of the antiviral nirmatrelvir-ritonavir (Paxlovid) didn't improve symptoms of long COVID, according to a randomized controlled trial that...
